Software provider EMIS lands share of £15m contract in Scotland

A Leeds healthcare software firm has landed a £15m contact for the provision of secondary care clinical systems across Scotland.
15 November 2015 .......    Chris Spencer, the chief executive of Emis Group plc speaks at The Yorkshire Post and aql Business Breakfast in Leeds. Picture Tony Johnson15 November 2015 .......    Chris Spencer, the chief executive of Emis Group plc speaks at The Yorkshire Post and aql Business Breakfast in Leeds. Picture Tony Johnson
15 November 2015 ....... Chris Spencer, the chief executive of Emis Group plc speaks at The Yorkshire Post and aql Business Breakfast in Leeds. Picture Tony Johnson

EMIS Health, based in the Rawdon area of the city, has won accreditation as a supplier of Hospital Electronic Prescribing and Medicines Administration (HEPMA) systems from NHS Scotland.

The company’s hospital pharmacy system is already used in seven health boards, and the company has a 51.5 per cent share of the GP market in Scotland.

Hide Ad
Hide Ad

EMIS Health is one of just two suppliers on the NHS Scotland HEPMA framework (which is rolling out electronic medicines management across hospitals).

It means that health boards are free to choose EMIS Health’s fully integrated suite of HEPMAeprescribing, medicines management and hospital pharmacy systems.

The technology uses intuitive touch screens with a drug chart layout that is familiar to clinicians, and allows them to prescribe according to their current practice rather than having to adapt to the constraints of an electronic system.

Duane Lawrence, managing director for EMIS Health secondary care said: “We are delighted to have landed this important business win, which shows our reach across the UK.

Hide Ad
Hide Ad

“North and south of the border, our systems are driving up standards of patient care, transforming ways of working for clinicians and introducing efficiencies that will save the NHS money.”

The contract comes just one month after the firm, which employs 1,200 people across the country, said that trading in the first half of 2016 had been in line with the board’s expectations despite a slower than expected rate of NHS contracts and the ubiquitous post-Brexit uncertainty.

It has recently upped the ante on its cost reduction programme which it anticipates will boost performance levels for the second half of the year.